Real World Observational Study of Sotatercept for Pulmonary Hypertension

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)

NCT03496207 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)

NCT06664801 ·Status: COMPLETED ·Phase: PHASE2

A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)

NCT04945460 ·Status: COMPLETED ·Phase: PHASE2

Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)

NCT06814145 ·Status: RECRUITING ·Phase: PHASE2

A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)

NCT04896008 ·Status: COMPLETED ·Phase: PHASE3

Sotatercept in Pulmonary Arterial Hypertension

NCT07140484 ·Status: RECRUITING ·Phase: PHASE4

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-031/LIGHTRAY EXTENSION)

NCT06925750 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

PAH Exercise Study

NCT06941441 ·Status: RECRUITING ·Phase: PHASE3

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

NCT04576988 ·Status: COMPLETED ·Phase: PHASE3

A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004/A011-12)

NCT04796337 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

NCT05587712 ·Status: RECRUITING ·Phase: PHASE2

The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.

NCT05908019 ·Status: UNKNOWN ·Phase: NA

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)

NCT00310830 ·Status: TERMINATED ·Phase: PHASE3

Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants

NCT05764265 ·Status: TERMINATED ·Phase: PHASE2

Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs

NCT03863990 ·Status: COMPLETED

Safety Surveillance of Targeted Drugs for Pulmonary Hypertension Using a Computerized Follow-up System: a Nationwide Cohort Study

NCT05372263 ·Status: RECRUITING

129 Xenon Imaging in Patients Treated With Sotatercept

NCT06351345 ·Status: RECRUITING ·Phase: PHASE2

Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension

NCT00046319 ·Status: COMPLETED ·Phase: PHASE2

Selonsertib in Adults With Pulmonary Arterial Hypertension

NCT02234141 ·Status: COMPLETED ·Phase: PHASE2

Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan

NCT01508780 ·Status: WITHDRAWN ·Phase: PHASE4

Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE

NCT01827059 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension

NCT00034307 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Repurposing Valsartan May Protect Against Pulmonary Hypertension

NCT06053580 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate GSK1325760A - a Long-Term Extension Study

NCT00554619 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Triple-targeted Drug Therapy in Treatment-naive Patients With Non-low-risk PAH: A Real-world, Multicenter Study

NCT06753981 ·Status: RECRUITING